Therefore, blocking the CD47-SIRPα interaction directly improves the macrophages’ ability to clear tumor cells, senescent red blood cells, and platelets, leading to adverse reactions (Khandelwal et al., 2007; Kwong et al., 2014). Here, CD47 is linked to neoplasm.